Tirilazad prevention of reperfusion edema after focal ischemia in cynomolgus monkeys

Canadian Journal of Neurological Sciences

Volumn 23, Issue 1, 1996, Pages 46-52

  Boisvert, Donald P ^a,b   Hall, Edward D ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Canadian Council on Animal Care   (Canada)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TIRILAZAD;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0029978305     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100039172     Document Type: Article

References (35)

1. Yang G-Y, Betz AL. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994; 25: 1658-1665.
2. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. Am J Physiol 1992; 263: H1356-H1362.
3. Wilson DF, Shintaro G, Pastuszko A, Greenberg JH. Microvascular damage in the cortex of cat brain from middle cerebral artery occlusion and reperfusion. J Appl Physiol 1993; 74: 580-589.
4. Anwar M, Costa O, Sinha AK, Weiss HR. Middle cerebral artery occlusion increases cerebral capillary permeability. Neurol Res 1993; 15: 232-236.
5. Betz AL. Oxygen free radicals and the brain microvasculature. In: Pardridge W, ed. The Blood-Brain Barrier. New York: Raven Press, 1993; 303-321.
6. Braughler JM, Hall ED. Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Rad Biol Med 1989; 6: 289-301.
7. Hall ED, Braughler JM. Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation. Free Rad Biol Med 1989; 6: 303-313.
8. Siesjo BK, Agardh C-D, Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989; 1: 165-211.
9. Asano T, Koide T, Gotoh O, et al. The role of free radicals and eicosanoids in the pathogenetic mechanism underlying ischemic brain edema. Mol Chem Neuropathol 1989; 10: 101-133.
10. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in CNS trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994; 28: 221-268.
11. Young W, Wojak JC, DeCrescito V. 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke 1988; 19: 1013-1019.
12. Lythgoe DJ, Little RA, O'Shaughnessy CT, Steward MC. Effect of U-74006F on oedema and infarct volumes following permanent occlusion of the middle cerebral artery in the rat. Br J Pharmacol 1990; 100: 454P.
13. Karki A, Westergren I, Widner H, Johansson B. Tinlazad reduces brain edema after middle cerebral artery ligation in hypertensive rats. Acta Neurochir 1994: 60 (Suppl.): 310-313.
14. Hall ED, Travis MA. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U-74006F. Brain Res 1988; 451: 350-352.
15. Zuccarello M, Anderson DK. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats. Stroke 1989; 20: 367-371.
16. Hall ED, Yonkers PA, Andrus PK, Cox JW, Anderson DK. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma 1992; 9 (Suppl. 2): S425-S442.
17. Smith SL, Andrus PK, Zhang JR, Hall ED. Direct measurement of hydroxyl radical levels, lipid peroxidation and blood-brain barrier disruption following unilateral head injury in the rat. J A Neurotrauma 1994; 11: 393-404.
18. Mathews WR, Marshcke CK, McKenna R. Tirilazad mesylate protects endothelium from damage by reactive oxygen. J Mol Cell Cardiol 1992; 24 (Suppl. III): 517.
19. Eversole RR, Smith SL, Beuving LJ, Hall ED. Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on hepatic endothelium in experimental hemorrhagic shock. Circ Shock 1993; 40: 125-131.
20. Hall ED, Pazara KE, Braughler JM. 21-Aminosteroid lipid peroxidation inhibitor U-74006F protects against cerebral ischemia in gerbils. Stroke 1988; 19: 997-1002.
21. Hall ED, Pazara KE, Braughler JM. Effects of tirilazad mesylate on post-ischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils. Stroke 1991; 22: 361-366.
22. Umemura K, Wada K, Uematsu T, Mizuno A, Nakashima M. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model. Eur J Pharmacol 1994; 25: 69-74.
23. Andrus PK, Hall ED, Taylor BM, Sam LM, Sun FF. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels in gerbil brain following ischemia and reperfusion. Brain Res 1994; 659: 126-132.
24. Gaetani P, Marzatico F, Lombardi D, Adinolfi D, Rodriguez y Baena R. Effects of high dose methylprednisolone and U-74006F on eicosanoid synthesis after subarachnoid hemorrhage in rats. Stroke 1991; 22: 215-220.
25. Black KL, Hoff JT. Leukotrienes increase blood-brain barrier permeability following intraparenchymal injection in rats. Ann Neurol 1985; 18: 349-351.
26. Lands WEM. Interactions of lipid hydroperoxides with eicosanoid biosynthesis. Free Rad Biol Med 1985; 1: 97-101.
27. Xue D, Slivka A, Buchan AM. Tirilazad reduces cortical infarction after transient, but not permanent focal cerebral ischemia in rats. Stroke 1992; 23: 894-899.
28. Beck T, Bielenberg GW. The effects of two 21-aminosteroids, on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain Res 1991; 560: 159-162.
29. Park CK, Hall ED. Dose-response analysis of the 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Brain Res 1994; 645: 157-163.
30. Silvia RC, Piercey MF, Hoffmann WE, et al. U-74006F, an inhibitor of lipid peroxidation, protects against lesion development following experimental stroke in the cat: histological and metabolic analysis. Soc Neurosci Abst 1987; 13: 1499.
31. Wilson JT, Bednar MM, McAuliffe TL, Raymond S, Gross CE. The effect of the 21-aminosteroid U-74006F in a rabbit model of thromboembolic stroke. Neurosurgery 1992; 31: 929-934.
32. Mori E, Copeland BR, Thomas WS, Koziol JA, DelZoppo GT. Effect of tirilazad mesylate on middle cerebral artery occlusion/reperfusion in non-human primates. Cerebrovasc Dis 1995; 5: 342-349.
33. Gelb AW, Henderson SM, Zhang C. U-74,006F, a 21-aminosteroid, does not ameliorate feline focal cerebral ischemia. J Neurosurg Anesthesiol 1990; 2: 240.
34. Myers RE, Kleinholz M, Wagner KR, de Courten-Myers GM. Effects of experimental aminosteroid on outcome of cerebrovascular occlusion in cats. Stroke 1990; 21: 179.
35. Takeshima R, Kirsch JR, Koehler RC, Traystman RJ. Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats. Stroke 1994; 25: 670-676.